Australia Stock Exchange release from EMYRIA : Recruitment commenced for EMD-RX5 Phase 1 Study
08/03/2022 22:47
Australia Stock Exchange release from EMYRIA EMD.AX : Recruitment commenced for EMD-RX5 Phase 1 Study
- AU$30.65m
- AU$24.15m
- AU$4.05m
Australia Stock Exchange release from EMYRIA EMD.AX : Recruitment commenced for EMD-RX5 Phase 1 Study